Watchlist Manager

Watchlist

Price: 17.02 HKD 0.24% Market Closed

Market Cap: HK$41.8B

G	Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd HKEX:874	CN
A	AMTD Digital Inc NYSE:HKD	SG
	Beijing Chunlizhengda Medical Instruments Co Ltd SSE:688236	CN
G	Gander Gold Corp CNSX:GAND	CA
	Saudi Cable Company SJSC SAU:2110	SA

Income Statement

Currency: CNY

	Dec-2003	Mar-2004	Jun-2004	Sep-2004	Dec-2004	Mar-2005	Jun-2005	Sep-2005	Dec-2005	Mar-2006	Jun-2006	Sep-2006	Dec-2006	Mar-2007	Jun-2007	Sep-2007	Dec-2007	Mar-2008	Jun-2008	Sep-2008	Dec-2008	Mar-2009	Jun-2009	Sep-2009	Dec-2009	Mar-2010	Jun-2010	Sep-2010	Dec-2010	Mar-2011	Jun-2011	Sep-2011	Dec-2011	Mar-2012	Jun-2012	Sep-2012	Dec-2012	Mar-2013	Jun-2013	Sep-2013	Dec-2013	Mar-2014	Jun-2014	Sep-2014	Dec-2014	Mar-2015	Jun-2015	Sep-2015	Dec-2015	Mar-2016	Jun-2016	Sep-2016	Dec-2016	Mar-2017	Jun-2017	Sep-2017	Dec-2017	Mar-2018	Jun-2018	Sep-2018	Dec-2018	Mar-2019	Jun-2019	Sep-2019	Dec-2019	Mar-2020	Jun-2020	Sep-2020	Dec-2020	Mar-2021	Jun-2021	Sep-2021	Dec-2021	Mar-2022	Jun-2022	Sep-2022	Dec-2022	Mar-2023	Jun-2023	Sep-2023	Dec-2023	Mar-2024	Jun-2024	Sep-2024	Dec-2024	Mar-2025	Jun-2025	Sep-2025	Dec-2025
Revenue
Interest Expense	20	0	0	0	28	0	0	0	45	0	0	0	47	0	0	0	72	0	0	0	15	0	0	0	8	0	0	0	2	0	0	0	6	0	0	0	58	0	0	0	35	0	0	0	25	0	0	0	32	0	0	0	17	0	0	1	1	2	29	161	227	317	390	366	374	365	366	327	363	371	391	426	418	441	422	419	434	406	418	424	446	441	434	431	418	413	0	0	0
Revenue	6 972 N/A	7 225 +4%	7 384 +2%	7 590 +3%	7 708 +2%	7 981 +4%	8 314 +4%	8 631 +4%	9 026 +5%	9 292 +3%	9 563 +3%	9 827 +3%	10 296 +5%	10 841 +5%	11 178 +3%	11 694 +5%	11 937 +2%	9 960 -17%	8 026 -19%	5 602 -30%	3 527 -37%	3 382 -4%	3 369 0%	3 667 +9%	3 882 +6%	4 088 +5%	4 260 +4%	4 416 +4%	4 486 +2%	4 622 +3%	4 981 +8%	5 174 +4%	5 440 +5%	5 889 +8%	8 272 +40%	9 840 +19%	12 063 +23%	14 389 +19%	16 666 +16%	17 925 +8%	17 608 -2%	18 129 +3%	17 374 -4%	17 857 +3%	18 800 +5%	18 858 +0%	19 259 +2%	19 235 0%	19 125 -1%	19 442 +2%	19 502 +0%	19 597 +0%	20 036 +2%	20 272 +1%	20 293 +0%	20 459 +1%	20 954 +2%	22 575 +8%	24 679 +9%	34 863 +41%	42 234 +21%	53 380 +26%	60 735 +14%	62 421 +3%	64 952 +4%	63 882 -2%	62 081 -3%	61 774 0%	61 674 0%	64 735 +5%	67 333 +4%	68 329 +1%	69 014 +1%	69 507 +1%	70 106 +1%	70 280 +0%	70 788 +1%	71 878 +2%	73 538 +2%	74 167 +1%	75 515 +2%	76 833 +2%	76 588 0%	76 391 0%	74 993 -2%	74 520 -1%	75 785 +2%	77 539 +2%	77 656 +0%
Gross Profit
Cost of Revenue	(5 599)	(5 863)	(6 010)	(6 218)	(6 336)	(6 566)	(6 843)	(7 116)	(7 498)	(7 740)	(7 997)	(8 246)	(8 538)	(9 010)	(9 331)	(9 785)	(10 129)	(8 304)	(6 542)	(4 395)	(2 483)	(2 456)	(2 442)	(2 657)	(2 835)	(2 959)	(3 064)	(3 174)	(3 236)	(3 344)	(3 690)	(3 864)	(4 087)	(4 463)	(5 932)	(6 879)	(8 246)	(9 641)	(10 962)	(11 915)	(11 823)	(12 192)	(11 750)	(11 901)	(12 214)	(12 337)	(12 497)	(12 466)	(12 218)	(12 360)	(12 479)	(12 613)	(13 425)	(13 768)	(13 852)	(13 862)	(13 068)	(14 332)	(16 386)	(25 492)	(32 225)	(41 754)	(48 293)	(49 397)	(52 093)	(52 065)	(50 898)	(50 935)	(51 257)	(53 791)	(55 674)	(56 458)	(55 793)	(56 240)	(56 993)	(57 331)	(57 516)	(58 699)	(59 953)	(60 377)	(61 331)	(62 947)	(63 265)	(63 748)	(62 494)	(62 769)	(63 710)	(64 952)	(65 113)
Gross Profit	1 373 N/A	1 362 -1%	1 374 +1%	1 371 0%	1 372 +0%	1 412 +3%	1 468 +4%	1 513 +3%	1 529 +1%	1 551 +1%	1 566 +1%	1 581 +1%	1 758 +11%	1 832 +4%	1 847 +1%	1 909 +3%	1 808 -5%	1 657 -8%	1 485 -10%	1 209 -19%	1 044 -14%	926 -11%	926 N/A	1 008 +9%	1 047 +4%	1 128 +8%	1 196 +6%	1 241 +4%	1 250 +1%	1 277 +2%	1 290 +1%	1 310 +2%	1 353 +3%	1 426 +5%	2 340 +64%	2 961 +27%	3 817 +29%	4 748 +24%	5 704 +20%	6 010 +5%	5 785 -4%	5 936 +3%	5 623 -5%	5 955 +6%	6 585 +11%	6 520 -1%	6 761 +4%	6 769 +0%	6 907 +2%	7 083 +3%	7 024 -1%	6 984 -1%	6 610 -5%	6 504 -2%	6 441 -1%	6 597 +2%	7 887 +20%	8 243 +5%	8 293 +1%	9 370 +13%	10 009 +7%	11 626 +16%	12 441 +7%	13 023 +5%	12 859 -1%	11 814 -8%	11 181 -5%	10 837 -3%	10 416 -4%	10 943 +5%	11 658 +7%	11 870 +2%	13 221 +11%	13 267 +0%	13 112 -1%	12 949 -1%	13 272 +2%	13 179 -1%	13 585 +3%	13 790 +2%	14 185 +3%	13 886 -2%	13 323 -4%	12 643 -5%	12 499 -1%	11 751 -6%	12 074 +3%	12 586 +4%	12 543 0%
Operating Income
Operating Expenses	(1 056)	(1 075)	(1 125)	(1 147)	(1 160)	(1 164)	(1 161)	(1 168)	(1 185)	(1 198)	(1 221)	(1 236)	(1 333)	(1 381)	(1 370)	(1 427)	(1 365)	(1 293)	(1 246)	(1 113)	(1 004)	(968)	(940)	(962)	(994)	(1 014)	(1 034)	(1 065)	(1 078)	(1 094)	(1 127)	(1 141)	(1 194)	(1 251)	(1 909)	(2 433)	(3 166)	(3 894)	(4 738)	(5 020)	(4 867)	(4 940)	(4 695)	(4 990)	(5 391)	(5 269)	(5 421)	(5 380)	(5 742)	(5 912)	(5 970)	(5 997)	(5 454)	(5 268)	(4 844)	(4 841)	(5 979)	(5 806)	(5 903)	(6 594)	(6 586)	(8 404)	(8 477)	(8 991)	(8 961)	(8 116)	(8 120)	(7 387)	(7 172)	(7 189)	(7 529)	(7 951)	(9 010)	(8 841)	(8 743)	(8 481)	(8 665)	(8 555)	(8 966)	(9 065)	(9 473)	(9 000)	(8 801)	(8 506)	(8 863)	(8 611)	(8 841)	(9 051)	(9 237)
Selling, General & Administrative	(1 098)	(1 116)	(1 165)	(1 188)	(1 190)	(1 204)	(1 202)	(1 212)	(1 221)	(1 226)	(1 230)	(1 232)	(1 325)	(1 370)	(1 359)	(1 412)	(1 356)	(1 274)	(1 221)	(1 093)	(1 000)	(931)	(919)	(947)	(992)	(1 031)	(1 047)	(1 070)	(1 075)	(1 097)	(1 132)	(1 147)	(1 191)	(1 253)	(1 907)	(2 431)	(2 845)	(3 879)	(4 725)	(5 005)	(4 507)	(4 584)	(4 340)	(4 631)	(5 028)	(5 209)	(5 352)	(5 321)	(5 341)	(5 872)	(5 945)	(5 968)	(5 032)	(5 288)	(4 887)	(4 893)	(5 624)	(5 908)	(5 831)	(6 390)	(6 872)	(7 670)	(8 110)	(8 589)	(8 361)	(7 984)	(7 810)	(7 134)	(6 330)	(6 858)	(6 978)	(7 303)	(7 903)	(8 184)	(8 364)	(8 106)	(7 891)	(8 287)	(8 427)	(8 666)	(8 357)	(8 642)	(8 461)	(8 068)	(7 769)	(7 774)	(8 055)	(8 315)	(8 174)
Research & Development	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	(244)	0	0	0	(282)	0	0	0	(279)	0	0	0	(314)	0	0	0	(330)	0	0	0	(373)	0	(242)	(392)	(558)	(756)	(619)	(656)	(543)	(539)	(569)	(516)	(577)	(664)	(729)	(814)	(837)	(927)	(930)	(934)	(778)	(760)	(779)	(735)	(738)	(789)	(773)	(781)	(719)	(721)	(658)	(629)	(608)
Depreciation & Amortization	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	(73)	0	0	0	(67)	0	0	0	(73)	0	0	0	(76)	0	0	0	(83)	0	0	0	(86)	0	0	0	(213)	0	0	0	(444)	0	0	0	(499)	0	0	0	(529)	0	0	0	(587)	0	0	0	(641)	0	0	0	(663)	0	0	0	(666)
Other Operating Expenses	42	43	40	43	30	42	42	45	36	29	10	(3)	(7)	(11)	(11)	(15)	(8)	(18)	(24)	(19)	(4)	(37)	(22)	(15)	(2)	17	13	4	(3)	2	6	6	(2)	1	(4)	(3)	(5)	(14)	(11)	(15)	(11)	(356)	(355)	(359)	(12)	(59)	(67)	(57)	(12)	(39)	(26)	(29)	(8)	19	44	53	103	102	170	189	1 058	23	252	253	387	406	258	264	233	333	177	168	259	270	551	560	591	492	240	335	263	430	432	344	288	(115)	(128)	(107)	211
Operating Income	317 N/A	289 -9%	251 -13%	226 -10%	212 -6%	250 +18%	309 +24%	346 +12%	343 -1%	353 +3%	344 -3%	344 N/A	426 +24%	450 +6%	477 +6%	482 +1%	443 -8%	363 -18%	238 -34%	94 -61%	40 -57%	(42) N/A	(14) +67%	47 N/A	53 +13%	114 +115%	162 +42%	177 +9%	172 -3%	184 +7%	164 -11%	169 +3%	159 -6%	175 +10%	432 +147%	529 +22%	650 +23%	856 +32%	968 +13%	993 +3%	918 -8%	999 +9%	930 -7%	966 +4%	1 195 +24%	1 252 +5%	1 342 +7%	1 390 +4%	1 164 -16%	1 171 +1%	1 053 -10%	988 -6%	1 157 +17%	1 237 +7%	1 599 +29%	1 757 +10%	1 907 +9%	2 438 +28%	2 390 -2%	2 777 +16%	3 423 +23%	3 223 -6%	3 965 +23%	4 032 +2%	3 898 -3%	3 699 -5%	3 062 -17%	3 452 +13%	3 245 -6%	3 755 +16%	4 129 +10%	3 920 -5%	4 211 +7%	4 426 +5%	4 369 -1%	4 468 +2%	4 607 +3%	4 625 +0%	4 619 0%	4 724 +2%	4 712 0%	4 886 +4%	4 521 -7%	4 137 -8%	3 637 -12%	3 141 -14%	3 233 +3%	3 535 +9%	3 306 -6%
Pre-Tax Income
Interest Income Expense	(18)	(21)	(28)	(32)	(34)	(47)	(53)	(54)	(43)	(30)	(14)	(5)	(30)	(51)	(40)	(42)	33	120	157	181	173	109	113	129	137	125	117	122	122	141	142	138	151	169	184	182	205	186	200	187	199	210	215	246	172	155	137	95	246	281	288	331	310	318	363	374	556	584	1 689	1 742	531	1 257	66	(36)	156	101	71	84	429	436	529	560	529	585	502	517	450	539	656	644	389	322	280	217	334	220	149	160	211
Non-Reccuring Items	0	0	0	0	0	0	0	0	0	0	0	0	(11)	0	0	0	(22)	0	0	0	(37)	0	0	0	17	0	0	0	4	0	0	0	(1)	0	0	0	0	0	0	0	3	0	0	0	(4)	0	0	0	0	0	0	0	0	0	0	0	(4)	0	0	(2)	(119)	0	0	0	(1)	1	4	6	(4)	3	0	(0)	43	1	1	(0)	12	1	1	1	21	12	11	10	(377)	10	14	15	107
Gain/Loss on Disposition of Assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	(2)	0	0	0	(1)	0	0	0	0	0	0	0	(1)	0	0	0	(1)	0	0	0	(1)	(1)	(2)	(3)	(4)	(5)	(4)	(3)	(9)	0	0	(8)	(1)	0	0	0	15	0	15	15	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5	0	0	0	5
Total Other Income	(14)	(13)	(11)	(13)	(11)	(10)	(9)	(7)	6	(2)	5	2	(3)	(1)	(2)	2	12	11	14	14	27	27	28	33	24	26	26	25	24	24	24	22	27	27	26	26	27	26	28	34	113	117	118	114	113	108	95	95	219	225	383	451	463	466	310	260	34	24	24	156	184	170	189	93	76	73	43	10	70	66	5	(12)	(60)	(66)	(7)	(10)	(27)	(30)	(32)	(31)	(12)	(13)	(5)	(0)	8	16	72	75	60
Pre-Tax Income	285 N/A	255 -11%	213 -16%	181 -15%	168 -7%	194 +15%	247 +27%	286 +16%	307 +7%	321 +5%	335 +4%	341 +2%	381 +12%	398 +4%	436 +10%	444 +2%	465 +5%	496 +7%	410 -17%	290 -29%	202 -30%	95 -53%	129 +36%	210 +63%	231 +10%	266 +15%	305 +15%	323 +6%	321 -1%	348 +8%	329 -5%	329 N/A	335 +2%	370 +10%	640 +73%	736 +15%	881 +20%	1 068 +21%	1 196 +12%	1 212 +1%	1 229 +1%	1 321 +7%	1 259 -5%	1 323 +5%	1 467 +11%	1 515 +3%	1 574 +4%	1 570 0%	1 628 +4%	1 676 +3%	1 724 +3%	1 768 +3%	1 945 +10%	2 021 +4%	2 287 +13%	2 406 +5%	2 493 +4%	3 046 +22%	4 103 +35%	4 674 +14%	4 019 -14%	4 650 +16%	4 220 -9%	4 089 -3%	4 129 +1%	3 875 -6%	3 181 -18%	3 553 +12%	3 739 +5%	4 260 +14%	4 664 +9%	4 468 -4%	4 723 +6%	4 945 +5%	4 866 -2%	4 975 +2%	5 043 +1%	5 134 +2%	5 244 +2%	5 339 +2%	5 110 -4%	5 208 +2%	4 807 -8%	4 364 -9%	3 608 -17%	3 386 -6%	3 469 +2%	3 786 +9%	3 690 -3%
Net Income
Tax Provision	(134)	(129)	(126)	(122)	(104)	(106)	(111)	(115)	(113)	(111)	(107)	(113)	(132)	(139)	(164)	(158)	(121)	(113)	(61)	(28)	(30)	(7)	(14)	(32)	(23)	(22)	(36)	(31)	(47)	(55)	(43)	(39)	(35)	(33)	(75)	(88)	(114)	(157)	(157)	(173)	(222)	(254)	(278)	(312)	(257)	(263)	(268)	(248)	(283)	(279)	(308)	(310)	(386)	(382)	(399)	(414)	(374)	(505)	(517)	(576)	(485)	(578)	(668)	(685)	(687)	(640)	(533)	(659)	(647)	(724)	(808)	(701)	(754)	(789)	(798)	(830)	(790)	(804)	(818)	(841)	(851)	(886)	(802)	(744)	(607)	(560)	(560)	(676)	(629)
Income from Continuing Operations	150	127	88	60	64	89	137	172	194	212	230	230	249	259	271	285	345	382	349	262	172	88	115	178	209	245	270	294	274	294	287	290	300	337	565	648	767	910	1 038	1 039	1 007	1 068	982	1 011	1 211	1 252	1 305	1 320	1 345	1 396	1 416	1 459	1 559	1 637	1 886	1 990	2 119	2 542	3 587	4 099	3 534	4 072	3 552	3 404	3 441	3 235	2 649	2 896	3 092	3 538	3 856	3 767	3 969	4 156	4 068	4 145	4 253	4 331	4 426	4 497	4 259	4 322	4 006	3 620	3 001	2 826	2 909	3 109	3 061
Income to Minority Interest	(11)	(9)	(8)	(9)	(9)	(10)	(10)	(11)	(10)	(10)	(11)	(9)	(12)	(12)	(13)	(16)	(10)	(10)	(5)	4	11	18	18	14	2	(2)	(5)	(7)	(7)	(7)	(8)	(10)	(12)	(15)	(31)	(35)	(38)	(41)	(40)	(39)	(27)	(32)	(24)	(11)	(18)	(13)	(12)	(25)	(45)	(50)	(58)	(62)	(51)	(56)	(53)	(54)	(57)	(60)	(65)	(84)	(93)	(130)	(183)	(243)	(252)	(269)	(243)	(207)	(176)	(179)	(203)	(200)	(249)	(258)	(261)	(262)	(287)	(261)	(238)	(214)	(204)	(217)	(212)	(197)	(165)	(128)	(107)	(123)	(78)
Net Income (Common)	140 N/A	115 -18%	77 -33%	49 -36%	55 +12%	78 +42%	126 +62%	160 +27%	184 +15%	200 +9%	218 +9%	220 +1%	238 +8%	247 +4%	258 +4%	269 +4%	335 +25%	371 +11%	343 -8%	265 -23%	182 -31%	106 -42%	133 +25%	192 +44%	211 +10%	242 +15%	263 +9%	285 +8%	267 -6%	286 +7%	279 -2%	280 +0%	288 +3%	323 +12%	535 +66%	614 +15%	729 +19%	869 +19%	998 +15%	1 000 +0%	980 -2%	1 036 +6%	958 -8%	1 000 +4%	1 192 +19%	1 239 +4%	1 294 +4%	1 296 +0%	1 300 +0%	1 345 +3%	1 356 +1%	1 396 +3%	1 508 +8%	1 584 +5%	1 835 +16%	1 938 +6%	2 062 +6%	2 482 +20%	3 523 +42%	4 015 +14%	3 441 -14%	3 943 +15%	3 370 -15%	3 162 -6%	3 189 +1%	2 966 -7%	2 405 -19%	2 688 +12%	2 915 +8%	3 358 +15%	3 653 +9%	3 567 -2%	3 720 +4%	3 898 +5%	3 807 -2%	3 883 +2%	3 967 +2%	4 069 +3%	4 188 +3%	4 283 +2%	4 056 -5%	4 105 +1%	3 794 -8%	3 423 -10%	2 835 -17%	2 699 -5%	2 802 +4%	2 987 +7%	2 983 0%
EPS (Diluted)	0.17 N/A	0.14 -18%	0.09 -36%	0.05 -44%	0.07 +40%	0.09 +29%	0.15 +67%	0.19 +27%	0.23 +21%	0.24 +4%	0.27 +13%	0.28 +4%	0.29 +4%	0.32 +10%	0.33 +3%	0.34 +3%	0.41 +21%	0.46 +12%	0.42 -9%	0.32 -24%	0.23 -28%	0.13 -43%	0.17 +31%	0.25 +47%	0.26 +4%	0.3 +15%	0.32 +7%	0.34 +6%	0.33 -3%	0.35 +6%	0.34 -3%	0.34 N/A	0.35 +3%	0.39 +11%	0.31 -21%	0.75 +142%	0.58 -23%	0.69 +19%	0.56 -19%	0.77 +37%	0.77 N/A	0.81 +5%	0.74 -9%	0.77 +4%	0.92 +19%	0.96 +4%	0.96 N/A	0.99 +3%	1.01 +2%	1.04 +3%	1.06 +2%	1.05 -1%	1.08 +3%	0.97 -10%	1.12 +15%	1.18 +5%	1.27 +8%	1.52 +20%	2.16 +42%	2.46 +14%	2.12 -14%	2.42 +14%	2.07 -14%	1.95 -6%	1.96 +1%	1.83 -7%	1.46 -20%	1.66 +14%	1.79 +8%	2.07 +16%	2.25 +9%	2.2 -2%	2.29 +4%	2.4 +5%	2.34 -3%	2.39 +2%	2.44 +2%	2.5 +2%	2.58 +3%	2.63 +2%	2.49 -5%	2.52 +1%	2.33 -8%	2.11 -9%	1.74 -18%	1.66 -5%	1.72 +4%	1.84 +7%	1.84 N/A

Income Statement Balance Sheet Cash Flow Statement

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
HKEX:874

Income Statement

Earnings Waterfall
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd

Income Statement
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd

See Also

Company

Help

Tools

Stocks

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd HKEX:874

Income Statement

Earnings Waterfall Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd

Income Statement Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd

See Also

Company

Help

Tools

Stocks

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
HKEX:874

Earnings Waterfall
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd

Income Statement
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd